Sun Pharmaceutical Industries Limited has informed the Exchange about Incorporation of a Subsidiary Company

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.2%1-day move

₹1678.00

prior close

₹1619.90

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.0-0.1+0.0-0.0+3.2+4.2+5.7+7.9+8.6+10.3+13.5+9.9+11.7+15.8

Up moveDown movePending

AI summary

Sun Pharmaceutical Industries Limited has announced the incorporation of a new subsidiary, Sun Pharma America, Inc., in the United States of America on April 23, 2026. The new subsidiary is 100% owned by Sun Pharma and will operate in the pharmaceutical industry. The company states this is for internal group structuring purposes. Initial capital consideration will be in cash. This is not a related party transaction as it involves a newly set-up company.

Likely market impact

This is a routine administrative filing for corporate restructuring and has no immediate impact on shareholders or stock price. It simply establishes a new wholly-owned subsidiary in the US market.